We have read with great interest the recent article by Rakela et al. ([@R1]) describing genetic alterations detected by whole exome sequencing in a cohort of 26 adult patients with acute liver failure of indeterminate etiology (ALF-IE). The authors conclude that 12 variants of 11 genes were significantly associated with (ALF-IE), particularly the stop codon of *SEPRINB11* identified in 23 of the 26 patients and the missense variant of *CYP2D6* detected in 13 patients*.* However, we have several key concerns regarding the results of the study.

First, Rakela et al. reported that the *SERPINB11* (c.268G\>T, p.Glu90Ter) variant, recorded as rs4940595 in the database of human single nucleotide polymorphism, was detected in most of the cohort. However, a careful examination of this variant using VarSome ([@R2]) and the latest update of the Broad Institute\'s gnomAD ([@R3]), a large database of human polymorphisms, reveals that this *SERPINB11* variant has a global allele frequency (AF) as high as 63% for all ethnic subgroups (Tables [1](#T1){ref-type="table"} and [2](#T2){ref-type="table"}). Thus, we cannot conclude that the variant is frequently associated with (ALF-IE). According to the pipeline of analysis described in the study (AF threshold of 0.01 in human polymorphism databases), this result can be explained by the fact that authors probably used the old version of gnomAD, in which all the variants and polymorphisms were not aligned with the new version of the genome and not the updated version of gnomAD. This update issue is also true for the second missense variant of *CYP2D6,* which has neither a high frequency nor an overall frequency for all ethnic subgroups in the updated gnomAD database (Tables [1](#T1){ref-type="table"} and [2](#T2){ref-type="table"}).

###### 

Extensive information on the variants detected by Rakela et al.

![](ct9-11-e00180-g001)

  Gene              rs              N        chr        GRCh38           REF              ALT                  Canonical RNA transcript   DNA                  Protein            Variant type    gnomAD E     gnomAD G
  ----------------- --------------- -------- ---------- ---------------- ---------------- -------------------- -------------------------- -------------------- ------------------ --------------- ------------ ------------
  ***SERPINB11***   **rs4940595**   **23**   **18**     **63712604**     **G**            **T**                **NM_080475.4**            **c.268G\>T**        **p.Glu90Ter**     **Non-sense**   **---**      **0.63**
  rs4940595         0               18       63712604   G                A                NM_080475.4          c.268G\>A                  p.Glu90Lys           Missense           ---             0.0000279    
  rs4940595         0               18       63712604   G                C                NM_080475.4          c.268G\>C                  p.Glu90Gln           Missense           ---             0.00000699   
  ***CYP2D6***      **rs1135840**   **16**   **22**     **42126611**     **C**            **G**                **NM_000106.6**            **c.1457G\>C**       **p.Ser486Thr**    **Missense**    **---**      **0.577**
  *ANTXRL*          rs7091749       8        10         46330066         C                A                    NM_001278688.2             c.1878C\>A           p.Pro626=          Synonymous      ---          0.000007
  rs7091749                         10       46330066   C                G                NM_001278688.2       c.1878C\>G                 p.Pro626=            Synonymous         ---             **0.194**    
  rs7091749                         10       46330066   C                T                NM_001278688.2       c.1878C\>T                 p.Pro626=            Synonymous         ---             **0.0103**   
  *MUC6*            rs776572312     9        11         1016887          G                A                    NM_005961.3                c.5914C\>T           p.Pro1972Ser       Missense        0.00002      **0.0118**
  *OR6J1*           rs1753430       14       14         22634064         A                G                    NM_001348233.1             c.748T\>C            p.Ser250Pro        Missense        ---          **0.41**
  *GNAL*            rs201898548     3        18         11689671         \_               GGCCCT               ENST00000334049.11         c.113_118dupTGGCCC   p.Leu38_Ala39dup   Insertion       **0.0842**   **0.141**
  rs201898548                       18       11689671   GGCCCT           \_               ENST00000334049.11   c.113_118delTGGCCC         p.Leu38_Ala39del     Inframe deletion   0.00104         **0.0168**   
  *AADACL3*         rs3010877       7        1          12719616         C                T                    NM_001103170.3             c.310C\>T            p.Pro104Ser        Missense        ---          **0.151**
  *MCL1*            rs11580946      3        1          150578851        G                A                    NM_021960.5                c.680C\>T            p.Ala227Val        Missense        0.00842      0.0086
  *CYP2D7*          rs56404506      11       22         42141186         C                T                    NM_001348386.3             c.1196G\>A           p.Arg399His        Missense        ---          **0.281**
  *CYP2D7*          rs1800754       15       22         42141587         G                A                    NM_001348386.3             c.932C\>T            p.Ser311Leu        Missense        ---          **0.48**
  rs1800754                         22       42141587   G                T                NM_001348386.3       c.932C\>A                  p.Ser311Ter          Non-sense          ---             ---          
  *RRP36*           rs200886831     9        6          43021676         \_               GCCGGG (6bp)         ENST00000244496.6          c.43_48dupGGGGCC     p.Gly15_Ala16dup   Insertion       0.000075     0.00104
  rs200886831                       6        43021676   GCCGGG (6bp)     \_               ENST00000244496.6    c.43_48delGGGGCC           p.Gly15_Ala16del     Inframe deletion   **0.0419**      **0.285**    
  rs200886831                       6        43021676   \_               GC...GG (12bp)   ENST00000244496.6    c.37_48dupGGGGCCGGGGCC     p.Gly13_Ala16dup     Insertion          ---             0.000014     
  rs200886831                       6        43021676   GC...GG (12bp)   \_               ENST00000244496.6    c.37_48del                 p.Gly13_Ala16del     Inframe deletion   0.000187        0.000961     
  *KIAA1161*        rs4879782       6        9          34372875         G                C                    NM_020702.5                c.69C\>G             p.Tyr23Ter         Non-sense       ---          **0.251**

ALT, alternative allele; Chr, chromosome; gnomAD, Allele frequency according to gnomAD exome database; gnomAD G, Allele frequency according to gnomAD genome database; GRCh38, position of the variant according to the last annotation of the human genome; N, number of patients with the variants in the cohort described by Rakela et al; REF, reference allele; rs: the identifier (ID) of the variant according to the last version of the human database of single nucleotide polymorphism (dbSNP 151)

###### 

AF in GnomAD genome (V3) database of the 2 variants of *SERPINB11* and *CYP2D6* reported by Rakela et al. in a cohort of adult patients with acute liver failure of indeterminate etiology
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  Population               *SERPINB11*: c.268G\>T, p.Glu90Ter (rs4940595)   *CYP2D6*: c.1457G\>C, p.Ser486Thr (rs1135840)                                                    
  ------------------------ ------------------------------------------------ ----------------------------------------------- -------- ----------- -------- --------- -------- -----------
  African                  21,033                                           41,932                                          5,329    **0.502**   26,148   40,822    8,881    **0.641**
  Amish                    604                                              900                                             199      **0.671**   466      884       128      **0.527**
  Ashkenazi Jewish         2,171                                            3,322                                           723      **0.654**   2,138    3,312     714      **0.646**
  East Asian               1,206                                            3,124                                           232      **0.386**   2,162    3,060     782      **0.707**
  European (Finnish)       6,987                                            10,438                                          2,314    **0.669**   5,217    10,388    1,330    **0.502**
  European (Non-Finnish)   46,721                                           64,532                                          16,858   **0.724**   35,748   64,030    10,432   **0.558**
  Latino                   8,124                                            13,646                                          2,430    **0.595**   6,615    13,548    1,734    **0.488**
  South Asian              1,904                                            3,028                                           597      **0.629**   1,663    2,972     489      **0.559**
  Other                    1,362                                            2,150                                           438      **0.633**   1,223    2,126     369      **0.575**
  Total                    90,112                                           143,072                                         29,120   **0.629**   81,380   141,142   24,859   **0.577**

AF, allele frequency.

Furthermore, *SERPINB11* is a unitary pseudogene in human genome ([@R4]). The pseudogene refers to a gene that has lost its functional counterpart during evolution because of a mutagenic event resulting in a premature stop codon. These mutagenic effects are often located in the initial portion of the coding gene, as for *SERPINB11.* Interestingly, *SERPINB11* has the particularity of being polymorphic in humans ([@R4]). Hence, the rs4940595 (G/T) variant distinguishes between individuals bearing a functional copy of *SERPINB11* with a wild-type c.268G allele and those bearing a nonfunctional copy, with the mutated c.268G\>T allele, introducing a stop codon. The extremely high frequency of the mutated allele of *SERPINB11* in the general population in different ethnic groups makes the link between this variant and ALF-IE in adults highly unlikely.

Finally, 5 of the 9 other variants located in *MUC6*, *OR6J1*, *AADACL3*, *CYP2D7*, and *KIAA1161* also occur frequently in the gnomAD genome, with an AF up to 40%. For the remaining 4 variants, the results can be considered inconclusive because they correspond to multiallelic polymorphisms which must be referenced precisely, theirs ID being insufficient (Table [1](#T1){ref-type="table"}). For instance, rs200886831 of *RRP36* detected in 9 patients, refers to 4 different alleles and corresponds to in-frame deletion or insertion of either 6 or 12 bp. One of the 4 alleles has an AF of 45% in gnomAD, whereas the other 3 are extremely rare.

Thus, the conclusion raised by Rakela et al. on the significant association of the 12 variants with ALF-IE in adults is incompatible with careful examination of recent databases. A careful processing of exome and genome data is necessary to find out genes causing ALF-IE in adults.
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